Michigan Medicine expert discusses Ketamine, a faster-acting antidepressant alternative
Current antidepressant medications work, but not for everyone. And when the medications do work, it can take a month or more for patients to experience a significant antidepressant effect. Active emeritus professor of pharmacology, Edward Domino, M.D., M.S., has been researching a faster-acting pharmaceutical agent known as ketamine.
Domino recently granted Michigan Video Abstracts an interview about his research with a substance known as ketamine (sometimes called “Special K”) and how it is used to treat depression. He discussed the pros and cons of using this treatment, and suggested future directions researchers might take to improve its therapeutic effectiveness.
Domino is a board-certified clinical pharmacologist, and has clinical training in general medicine, anesthesiology and psychiatry. He has been studying the efficacy of ketamine for more than 50 years, including the analgesic and anesthetic effects.
- Read Domino’s ResearchGate profile
- Domino, et al. Taming the ketamine tiger. Classic papers revisited. Anesthesiology 2010; 113(3): 678-686.
- Read about Domino’s work on the Department of Pharmacology Domino Lab website
- Check out Michigan Video Abstracts, a novel online forum for biomedical research, learning, and scholarship at Michigan Medicine